Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumab

J Thorac Oncol. 2011 Nov;6(11):1960-1. doi: 10.1097/JTO.0b013e31822e726f.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / pathology
  • Adult
  • Angiogenesis Inhibitors / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bevacizumab
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Female
  • Humans
  • Humeral Head / pathology*
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Osteonecrosis / chemically induced*
  • Prognosis

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab